Status:
COMPLETED
Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia
Lead Sponsor:
Hiroshima University
Collaborating Sponsors:
Kaneka Corporation
Conditions:
Hyperuricemia
Eligibility:
MALE
30-60 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the efficacy and dose-dependency of chrysanthemum flower oil in suppressing serum uric acid.
Eligibility Criteria
Inclusion
- Serum uric acid 6.8-8.9 mg/dL
Exclusion
- Taking anti-hyperuricemic drugs
- History of gouty attack
- Taking drugs or functional food that may affect serum uric acid level
- Hypertention, hyperlipidemia, or diabetes millitus
- Participation in any clinical trial within 90 days of the commencement of the trial
- Renal or hepatic dysfunction
- Heart disease
- History of severe disease and/or major surgery
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT02213562
Start Date
July 1 2014
End Date
March 1 2016
Last Update
August 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hiroshima University
Hiroshima, Japan, 734-8551